Repurposing disulfiram to induce OSCC cell death by cristae dysfunction promoted autophagy

Zhen Wang1, Han Jiang1, Lu-Yao Cai1

  • 1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Medicine of Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Oral Diseases
|September 29, 2020
PubMed
Abstract

Insights

Disulfiram suppresses oral squamous cell carcinoma by disrupting mitochondrial energy production, leading to excessive autophagy and cell death. Targeting OPA1-dependent ATP generation offers a new therapeutic strategy for oral cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Disulfiram (DSF) shows potential for cancer treatment but its mechanisms in oral squamous cell carcinoma (OSCC) are not fully understood.
  • Investigating novel therapeutic strategies is crucial for improving OSCC patient outcomes.

Purpose of the Study:

  • To evaluate the anti-cancer effects of disulfiram in oral squamous cell carcinoma.
  • To elucidate the molecular mechanisms underlying disulfiram's anti-tumor activity in OSCC.

Main Methods:

  • Cytotoxicity assays were performed using 3D culture and patient-derived xenograft (PDX) models of OSCC.
  • Analysis included cell proliferation, apoptosis, signaling pathways, mitochondrial respiration, and mitochondrial mass.
  • Mitochondrial DNA copy number and mitochondrial complex activities were assessed.

Main Results:

  • Disulfiram induced excessive autophagy in OSCC cells by impairing oxidative phosphorylation (OXPHOS).
  • DSF treatment led to OPA1 degradation, reducing mitochondrial respiration and ATP production.
  • Energy depletion activated AMPK, resulting in excessive autophagy and cell death, which was rescued by exogenous ATP.

Conclusions:

  • Disulfiram targets the mitochondrial inner membrane protein OPA1, disrupting cellular energy supply and inducing autophagy and cell death in OSCC.
  • OPA1-dependent ATP generation is a potential therapeutic target for oral squamous cell carcinoma treatment.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.0K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
8.8K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.8K